首页> 美国卫生研究院文献>other >How Cardiologists Present the Benefits of Percutaneous Coronary Interventions to Patients With Stable Angina

【2h】

How Cardiologists Present the Benefits of Percutaneous Coronary Interventions to Patients With Stable Angina

机译：心脏病专家如何向稳定型心绞痛患者介绍经皮冠状动脉介入治疗的益处

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

摘要
著录项
相似文献
相关主题

摘要

ImportancePatients with stable coronary artery disease (CAD) attribute greater benefit to percutaneous coronary interventions (PCI) than indicated in clinical trials. Little is known about how cardiologists' presentation of the benefits and risks may influence patients' perceptions.

机译：重要性与临床试验中指出的相比，具有稳定冠状动脉疾病（CAD）的患者对经皮冠状动脉介入治疗（PCI）的受益更大。对于心脏病专家对利益和风险的表述如何影响患者的看法知之甚少。

著录项

期刊名称 other
作者
Sarah L. Goff; Kathleen M. Mazor; Henry H. Ting; Reva Kleppel; Michael B. Rothberg;
展开▼
作者单位

展开▼
年(卷),期 -1(174),10
年度 -1
页码 1614–1621
总页数 17
原文格式 PDF
正文语种
中图分类
关键词

相似文献

外文文献
中文文献
专利

1. How cardiologists present the benefits of percutaneous coronary interventions to patients with stable angina: A qualitative analysis [J] . GoffS.L., MazorK.M., TingH.H., JAMA internal medicine . 2014,第10期

机译：心脏病专家如何向稳定型心绞痛患者介绍经皮冠状动脉介入治疗的益处：定性分析
2. Patients' and cardiologists' perceptions of the benefits of percutaneous coronary intervention for stable coronary disease. [J] . Schenker Y, Meisel A Annals of Internal Medicine . 2011,第5期

机译：患者和心脏病专家对经皮冠状动脉介入治疗稳定冠心病的益处的认识。
3. Patients' and Cardiologists' Perceptions of the Benefits of Percutaneous Coronary Intervention for Stable Coronary Disease [J] . Michael B. Rothberg Senthil K. Sivalingam Javed Ashraf Paul Visintainer John Joelson Reva Kleppel Neelima Vallurupalli and Marc J. Schweiger Annals of Internal Medicine . 2010,第5期

机译：患者和心脏病专家对经皮冠状动脉介入治疗稳定冠心病益处的看法
4. Evaluation of Oxidized Low-Density Lipoprotein in the Coronary Circulation of Patients with Coronary Artery Disease, and its Association with Percutaneous Coronary Intervention [C] . M.M. Ramadan, M. Kodama, S. Hirono, International Congress on Coronary Artery Disease . 2007

机译：冠状动脉疾病患者冠状动脉循环中氧化低密度脂蛋白的评价及其与经皮冠状动脉介入的关联
5. The Association between Unfractionated Heparin and Bivalirudin Used during Percutaneous Coronary Intervention for Stable Angina and Acute Coronary Syndromes and the In-Hospital and Mortality Outcomes Observed across All Body Mass Index Groups [D] . Chen, Christine. 2021

机译：在所有体重指数群体中观察到稳定冠状动脉干预期间使用经皮冠状动脉介入和急性冠状动脉综合征的冠状动脉介入和医院和死亡率结果之间的联合肝素和Bivalirudin之间的关联
6. Beneficial effects of fluvastatin following percutaneous coronary intervention in patients with unstable and stable angina: results from the Lescol intervention prevention study (LIPS) [O] . C H Lee, P de Feyter, P W Serruys, 2004

机译：不稳定和稳定型心绞痛患者经皮冠状动脉介入治疗后氟伐他汀的有益作用：莱斯科尔预防干预研究（LIPS）的结果
7. How cardiologists present the benefits of percutaneous coronary interventions to patients with stable angina: a qualitative analysis [O] . Goff, Sarah L., Mazor, Kathleen M., Ting, Henry H., 2014

机译：心脏病专家如何向稳定型心绞痛患者提供经皮冠状动脉介入治疗的益处：定性分析

How Cardiologists Present the Benefits of Percutaneous Coronary Interventions to Patients With Stable Angina

摘要

著录项

相似文献

相关主题

期刊订阅